Thymoquinone-loaded nanostructured lipid carrier reduces proliferation of human liver cancer cells, HepG2
Introduction: Hepatocellular carcinoma is one of the most common cancers that affected human in more than half of the world population. Although there is yet any alternatives treatment found for this disease, the antitumor property of thymoquinone has been well studied in most of cancer cell lines....
Saved in:
| Main Authors: | Mustafa Azmy, Nurfahima, Haron, Aminah Suhaila, Syed Alwi, Sharifah Sakinah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
2019
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/70036/1/2019070210002006_MJMHS_SP2_2019.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017) -
Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017) -
Effects of thymoquinone and thymoquinone-loade nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2 /
by: Aminah Suhaila Haron.
Published: (2018) -
Effects of thymoquinone (TQ) and thymoquinone-loaded nanostructured lipid carrier (TQ-NLC) on the morphological changes and cell cycle arrest in human liver carcinoma, HepG2 cell line /
by: Nurfahima Mustafa Azmy.
Published: (2017) -
The anti-proliferative effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on HepG2 and MCF7 cells /
by: Rafiqi Ab Rahim.
Published: (2015)
